Welcome to the European Association for Cancer Research
Europe’s membership association for cancer researchers

Making it Personal: Cancer Precision Medicine

Bergamo, Italy : 5 - 7 November 2018



Click here to download the PDF Programme and Abstract Book for the conference.


Click here for a mobile-friendly overview of the scientific programme

After two highly-rated previous editions, the 3rd EACR conference on the topic of personalised medicine will update you on the latest challenges and advances in targeted and immunological cancer therapies. It will cover a broad spectrum of basic, translational and clinical research, all related to currently pressing questions relevant across cancer types.

The multidisciplinary programme will encompass developments in diagnosis and early detection, including novel bioinformatic approaches. New immuno-oncology treatments will also be presented, emphasising the role of the tumour microenvironment and showcasing systems immunology. The emergence and role of drug-tolerant tumour fractions will be discussed in the context of drug resistance. And, reflecting one of the major needs, there will be a focus on rational design of combinatorial therapies and on how advances emerging from the laboratory are clinically implemented.

The programme includes 17 plenary lectures, dedicated poster sessions and interactive elements. The small size of the conference makes it an excellent forum to share new data, and to network with colleagues and speakers.

Who should attend?

We welcome all basic, translational and clinical scientists (including postdocs and trainees), who are interested in tackling pressing cancer-relevant questions, and who want to hear the latest developments in therapies targeting cancer and immune cells. We also invite industry scientists who are interested in targets for novel therapies. This is an excellent forum for informal networking and meeting potential collaborators.

Topics to be covered

  • Diagnosis
  • Early detection
  • Tumour microenvironment
  • Immuno-oncology
  • Targeted tumour therapy
  • Drug tolerance
  • Computational discovery of cancer vulnerabilities
  • Therapy resistance
  • Clonal evolution
  • Rational treatment combinations
  • Clinical implementation of exceptional responder data

Scientific Programme Committee

Johanna Joyce SWITZERLAND, Richard Marais UK, Daniel Peeper (chair) NETHERLANDS, Ze'ev Ronai ISRAEL / USA

Key dates

Bursary application deadline:
03 September 2018

Abstract submission deadline:
16 September 2018

Registration deadline:
01 October 2018

Above: the venue, the beautiful city of Bergamo

“It was really focused, up-to-date, friendly and interactive meeting. I loved that not only translational, but also clinical aspects were addressed.”

- participant feedback from the last edition of the meeting

98% of the participants from the last edition would recommend the conference to others.

Sorry. You need to upgrade your browser

You are using Internet Explorer 8

This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.

Thank you.